Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.95)
# 622
Out of 5,102 analysts
467
Total ratings
45.13%
Success rate
12.57%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Maintains: Buy | $70 → $45 | $15.36 | +192.97% | 14 | Dec 2, 2025 | |
| CORT Corcept Therapeutics | Reiterates: Buy | $145 | $87.13 | +66.42% | 25 | Nov 25, 2025 | |
| MDWD MediWound | Maintains: Buy | $31 → $36 | $19.26 | +86.92% | 20 | Nov 21, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $7.39 | +170.64% | 4 | Nov 19, 2025 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | $4 → $6 | $4.68 | +28.21% | 16 | Nov 18, 2025 | |
| LFWD Lifeward | Maintains: Buy | $13 → $4.5 | $0.71 | +536.04% | 8 | Nov 18, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $130 → $155 | $105.83 | +46.46% | 5 | Nov 17, 2025 | |
| CELC Celcuity | Downgrades: Neutral | $77 → $94 | $100.77 | -6.72% | 11 | Nov 17, 2025 | |
| PGEN Precigen | Maintains: Buy | $8.5 → $9 | $3.62 | +148.62% | 14 | Nov 14, 2025 | |
| VOR Vor Biopharma | Maintains: Buy | $55 → $32 | $12.13 | +163.81% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.28 | +40.09% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $47 | $41.63 | +12.90% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $3.88 | +28.87% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $81 | $65.72 | +23.25% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $2.5 | $0.29 | +764.75% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.85 | +170.27% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $6.41 | +243.21% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.92 | +224.82% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $30 | $10.39 | +188.74% | 15 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $6.45 | +148.06% | 14 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.90 | +478.95% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.41 | +13.38% | 10 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $3.40 | +341.18% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.31 | +129.01% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.30 | +438.46% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $16.90 | +107.10% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.40 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.99 | +202.15% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.52 | +31.58% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.72 | +103.49% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.35 | +708.51% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.84 | +82.29% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $1.73 | +10,304.62% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.82 | +418.67% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $37.41 | +60.38% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $7.45 | +342.95% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.59 | +747.46% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.95 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.16 | +53.63% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $4.59 | +335.73% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.87 | +53.32% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.27 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.71 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.67 | +1,397.01% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.76 | +183.45% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $3.78 | +3,074.60% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $0.94 | +1,183.42% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.78 | +2,453.63% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.75 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $8.41 | -28.66% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $2.14 | +600.93% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $9.43 | +249.95% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $19.91 | -52.29% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.20 | +1,166,663.90% | 1 | Mar 5, 2020 |
Janux Therapeutics
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $15.36
Upside: +192.97%
Corcept Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $145
Current: $87.13
Upside: +66.42%
MediWound
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $19.26
Upside: +86.92%
Actuate Therapeutics
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $7.39
Upside: +170.64%
Ekso Bionics Holdings
Nov 18, 2025
Maintains: Buy
Price Target: $4 → $6
Current: $4.68
Upside: +28.21%
Lifeward
Nov 18, 2025
Maintains: Buy
Price Target: $13 → $4.5
Current: $0.71
Upside: +536.04%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $105.83
Upside: +46.46%
Celcuity
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $100.77
Upside: -6.72%
Precigen
Nov 14, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $3.62
Upside: +148.62%
Vor Biopharma
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $12.13
Upside: +163.81%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $9.28
Upside: +40.09%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $41.63
Upside: +12.90%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $3.88
Upside: +28.87%
Nov 5, 2025
Maintains: Buy
Price Target: $80 → $81
Current: $65.72
Upside: +23.25%
Nov 4, 2025
Assumes: Buy
Price Target: $2.5
Current: $0.29
Upside: +764.75%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.85
Upside: +170.27%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $6.41
Upside: +243.21%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.92
Upside: +224.82%
Oct 20, 2025
Maintains: Buy
Price Target: $31 → $30
Current: $10.39
Upside: +188.74%
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $6.45
Upside: +148.06%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $1.90
Upside: +478.95%
Aug 19, 2025
Reiterates: Buy
Price Target: $5
Current: $4.41
Upside: +13.38%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $3.40
Upside: +341.18%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.31
Upside: +129.01%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.30
Upside: +438.46%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $16.90
Upside: +107.10%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.40
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $0.99
Upside: +202.15%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.52
Upside: +31.58%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.72
Upside: +103.49%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.35
Upside: +708.51%
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $3.84
Upside: +82.29%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $1.73
Upside: +10,304.62%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $4.82
Upside: +418.67%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $37.41
Upside: +60.38%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $7.45
Upside: +342.95%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.59
Upside: +747.46%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.95
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.16
Upside: +53.63%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $4.59
Upside: +335.73%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.87
Upside: +53.32%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.27
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.71
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.67
Upside: +1,397.01%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.76
Upside: +183.45%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $3.78
Upside: +3,074.60%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $0.94
Upside: +1,183.42%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.78
Upside: +2,453.63%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $13.75
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $8.41
Upside: -28.66%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $2.14
Upside: +600.93%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $9.43
Upside: +249.95%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $19.91
Upside: -52.29%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.20
Upside: +1,166,663.90%